Good Start Genetics Deepens Relationship with Amazon offering a First of its Kind Online Ashkenazi Jewish Carrier Screening Test

CAMBRIDGE, Mass., May 11, 2017 /PRNewswire/ -- Good Start Genetics, a leading family genomics company, today announced the expansion of VeriYou™, the Company's physician-ordered, genetic counseling-supported, at-home carrier screening tests, to now include screening for 19 inherited genetic disorders more prevalent in the Ashkenazi Jewish population. The National Jewish Genetic Consortium and medical guidelines recommend screening for these disorders among those of Ashkenazi Jewish descent. Good Start Genetics is the first company to bring clinical-grade, physician-ordered and affordable carrier screening tests into the home, accompanied by access to board-certified genetic counselors. According to the National Institutes of Health (NIH), nearly one in five people of Ashkenazi Jewish descent are carriers of a Jewish genetic disorder.

"We are committed to broadening access and removing barriers to best-in-class testing for mass clinical markets," said Jeffrey Luber, Good Start's president and CEO. "Healthcare is rapidly changing in a way that enables new delivery models in reproductive health that broaden access and affordability for millions. Central to our commitment to responsible testing, is our inclusion of physician ordering and world-class genetic counseling with every test, and at price points not previously seen in the market."

In November 2016, the Company announced its partnership with Amazon as the first genetic testing company with a direct relationship with the online retailer. In addition to the flagship VeriYou CF/SMA test, which offers testing for cystic fibrosis and spinal muscular atrophy, the newest addition, the VeriYou AJ/SMA test, offering testing for the spinal muscular atrophy and the 17 most prevalent genetic disorders in the Ashkenazi Jewish population, will also be available for purchase on Amazon.com or direct at Veriyou.com. The VeriYou AJ/SMA test includes screening for cystic fibrosis and spinal muscular atrophy, the two most common inherited genetic disorders in the U.S., and the 17 additional genetic disorders most common in the Ashkenazi Jewish population, including, Bloom's syndrome, Canavan disease, dihydrolipoamide dehydrogenase deficiency, familial dysautonomia, familial hyperinsulinism, Fanconi anemia (group C), Gaucher disease, glycogen storage disease type 1a, Joubert syndrome 2, maple syrup urine disease type 1A/1B, mucolipidosis type IV, Nemaline myopathy, Niemann-Pick disease type A/B, Tay-Sachs disease, Usher syndrome type III, Usher syndrome type IF, Walker-Warburg syndrome.                                                   

About Good Start Genetics:
Good Start Genetics is dedicated to women's health and helping grow healthy families through its best-in-class genetics offerings. Using advanced clinical sequencing, proprietary methods and information tailored to the individual, the Company's suite of offerings arms clinicians and patients with insightful and actionable information to promote successful pregnancies and help build healthy families. The Company's product portfolio, including GeneVu, EmbryVu and VeriYou, encompasses a multifaceted approach to genetic testing, featuring solutions for both preimplantation and carrier screening, while offering comprehensive and flexible testing options helping a wider range of couples find their paths to pregnancy at significantly lower costs. Good Start Genetics complements these offerings with world class customer care and genetic counseling to help families stay well-informed and be better prepared for tomorrow. For more information, please visit www.goodstartgenetics.com or join us on Facebook, Twitter and LinkedIn.

SOURCE Good Start Genetics